We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Five health systems representing hundreds of U.S. hospitals plan to establish their own non-profit generic drug company to address drug shortages and bring competition to the generic drug market. Read More
The suit alleges Cydan violated a September 2013 confidentiality agreement that barred the company from using the patients’ data for any reason beyond a possible joint venture. Read More
The co-conspirators also told doctors to have Medicare patients take medically unnecessary spinal facet joint injections to obtain prescriptions. Read More
The parents of twin girls with a rare genetic disorder sued a drugmaker and therapy accelerator for misappropriating the children’s trial data to secure a breakthrough therapy designation. Read More
A Michigan clinic manager pleaded guilty to a scheme to unnecessarily prescribe controlled substances that lost Medicare $131 million, and Attorney General Jeff Sessions called the plea the latest victory in Justice Department efforts against those exploiting the opioid addiction epidemic. Read More
A charity that helps low-income patients buy prescription drugs sued the federal government, claiming federal overreach left it unable to communicate with donors. Read More
The U.S. Court of Appeals for the Federal Circuit found that a district court was overly broad in its interpretation of patents in a lawsuit by a Teva subsidiary accusing Apotex of infringing its patents for the coating on a muscle relaxant pill. Read More